Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023 45.0% Revenue growth, 20233 Where the money goes Where each dollar of revenue went, fiscal 2023 Cost of revenue Research and development Other costs
Cost of revenue 52¢ $23.3M Research and development 25¢ $11.2M Other costs 23¢ $10.2M Income tax 0¢ $145.0K Out of $44.9M in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 3 $44.9M in 2023+218% since 2019 0 $20.0M $40.0M $60.0M 2019: $14.1M $14.1M 2019 2020: $16.5M $16.5M 2020 +17% 2021: $22.2M $22.2M 2021 +34% 2022: $30.9M $30.9M 2022 +40% 2023: $44.9M $44.9M 2023 +45% Gross profit4 5 6 3 $21.5M in 2023+360% since 2019 0 $10.0M $20.0M $30.0M 2019: $4.7M $4.7M 2019 2020: $6.8M $6.8M 2020 +45% 2021: $10.0M $10.0M 2021 +47% 2022: $14.0M $14.0M 2022 +39% 2023: $21.5M $21.5M 2023 +54% Operating income4 5 6 3 -$18.8M in 2023+12% since 2019 -$30.0M -$20.0M -$10.0M 0 2019: -$16.7M -$16.7M 2019 2020: -$13.7M -$13.7M 2020 −18% 2021: -$17.6M -$17.6M 2021 +28% 2022: -$22.4M -$22.4M 2022 +27% 2023: -$18.8M -$18.8M 2023 −16% Net income4 5 6 3 -$19.2M in 2023+4% since 2019 -$30.0M -$20.0M -$10.0M 0 2019: -$18.5M -$18.5M 2019 2020: -$15.6M -$15.6M 2020 −16% 2021: -$17.5M -$17.5M 2021 +12% 2022: -$24.4M -$24.4M 2022 +40% 2023: -$19.2M -$19.2M 2023 −22% Revenue7 8 $13.7M in Q2 FY2024+1% since Q1 FY2024 0 $5.0M $10.0M $15.0M Q1 FY2024: $13.5M $13.5M Q1 FY2024 Q2 FY2024: $13.7M $13.7M Q2 FY2024 +1% Gross profit7 8 $6.5M in Q2 FY2024+2% since Q1 FY2024 0 $2.0M $4.0M $6.0M $8.0M Q1 FY2024: $6.3M $6.3M Q1 FY2024 Q2 FY2024: $6.5M $6.5M Q2 FY2024 +2% Operating income7 8 -$8.7M in Q2 FY2024+36% since Q1 FY2024 -$10.0M -$7.5M -$5.0M -$2.5M 0 Q1 FY2024: -$6.4M -$6.4M Q1 FY2024 Q2 FY2024: -$8.7M -$8.7M Q2 FY2024 +36% Net income7 8 -$8.4M in Q2 FY2024+30% since Q1 FY2024 -$10.0M -$7.5M -$5.0M -$2.5M 0 Q1 FY2024: -$6.5M -$6.5M Q1 FY2024 Q2 FY2024: -$6.5M -$6.5M Q2 FY2024 +0% Q2 FY2024: -$8.4M -$8.4M Q2 FY2024 +30% Fiscal year 2018 2019 2020 2021 2022 2023 Revenue $14.1M4 $16.5M5 $22.2M6 $30.9M3 $44.9M3 Cost of revenue $9.4M4 $9.7M5 $12.2M6 $17.0M6 $23.3M3 Gross profit $4.7M4 $6.8M5 $10.0M6 $14.0M3 $21.5M3 Research and development $7.0M4 $4.5M5 $6.7M6 $10.1M3 $11.2M3 Operating income -$16.7M4 -$13.7M5 -$17.6M6 -$22.4M3 -$18.8M3 Interest $3.1K9 Income tax $47.0K6 $111.0K3 $145.0K3 Net income -$18.5M4 -$15.6M5 -$17.5M6 -$24.4M3 -$19.2M3 Earnings per share -$0.606 -$0.653 -$0.443 Earnings per share (diluted) -$0.606 -$0.653 -$0.443
Total assets9 4 5 6 3 $66.7M in 2023+266847900% since 2018 0 $20.0M $40.0M $60.0M $80.0M 2018: $25 $25 2018 2019: $15.7M $15.7M 2019 +62955968% 2020: $27.9M $27.9M 2020 +77% 2021: $52.1M $52.1M 2021 +86% 2022: $33.6M $33.6M 2022 −35% 2023: $66.7M $66.7M 2023 +98% Total liabilities9 4 5 6 3 $43.4M in 2023+125496% since 2018 0 $20.0M $40.0M $60.0M 2018: $34.5K $34.5K 2018 2019: $27.0M $27.0M 2019 +78046% 2020: $24.8M $24.8M 2020 −8% 2021: $28.0M $28.0M 2021 +13% 2022: $32.2M $32.2M 2022 +15% 2023: $43.4M $43.4M 2023 +35% Shareholders’ equity9 4 6 3 $23.3M in 2023-$75.0M -$50.0M -$25.0M 0 $25.0M 2018: -$34.5K -$34.5K 2018 2019: -$65.1M -$65.1M 2019 +188590% 2020: $3.1M $3.1M 2020 2021: $24.1M $24.1M 2021 +671% 2022: $1.5M $1.5M 2022 −94% 2023: $23.3M $23.3M 2023 +1491% Cash4 5 6 3 $46.2M in 2023+366% since 2018 0 $20.0M $40.0M $60.0M 2018: $9.9M $9.9M 2018 2019: $9.6M $9.6M 2019 −3% 2020: $20.8M $20.8M 2020 +116% 2021: $41.3M $41.3M 2021 +99% 2022: $21.3M $21.3M 2022 −48% 2023: $46.2M $46.2M 2023 +117% Long-term debt4 5 6 $750.0K in 2022+15% since 2020 0 $500.0K $1.0M $1.5M 2020: $650.0K $650.0K 2020 2021: $1.1M $1.1M 2021 +73% 2022: $750.0K $750.0K 2022 −33% Total assets7 8 $53.7M in Q2 FY2024−20% since Q1 FY2023 0 $20.0M $40.0M $60.0M $80.0M Q1 FY2023: $66.7M $66.7M Q1 FY2023 Q2 FY2023: $66.7M $66.7M Q2 FY2023 +0% Q1 FY2024: $59.6M $59.6M Q1 FY2024 −11% Q2 FY2024: $53.7M $53.7M Q2 FY2024 −10% Total liabilities7 8 $43.2M in Q2 FY2024−0% since Q1 FY2023 0 $20.0M $40.0M $60.0M Q1 FY2023: $43.4M $43.4M Q1 FY2023 Q2 FY2023: $43.4M $43.4M Q2 FY2023 +0% Q1 FY2024: $41.8M $41.8M Q1 FY2024 −4% Q2 FY2024: $43.2M $43.2M Q2 FY2024 +3% Shareholders’ equity7 8 $10.5M in Q2 FY2024−55% since Q1 FY2023 0 $10.0M $20.0M $30.0M Q1 FY2023: $23.3M $23.3M Q1 FY2023 Q2 FY2023: $23.3M $23.3M Q2 FY2023 +0% Q1 FY2024: $17.8M $17.8M Q1 FY2024 −24% Q2 FY2024: $17.8M $17.8M Q2 FY2024 +0% Q2 FY2024: $10.5M $10.5M Q2 FY2024 −41% Cash7 8 $28.2M in Q2 FY2024−39% since Q1 FY2023 0 $20.0M $40.0M $60.0M Q1 FY2023: $46.2M $46.2M Q1 FY2023 Q2 FY2023: $46.2M $46.2M Q2 FY2023 +0% Q1 FY2024: $37.3M $37.3M Q1 FY2024 −19% Q2 FY2024: $28.2M $28.2M Q2 FY2024 −24% Fiscal year 2018 2019 2020 2021 2022 2023 Cash $9.9M4 $9.6M4 $20.8M5 $41.3M6 $21.3M3 $46.2M3 Current assets $259 $14.4M4 $26.8M5 $50.8M6 $29.6M3 $56.8M3 Total assets $259 $15.7M4 $27.9M5 $52.1M6 $33.6M3 $66.7M3 Current liabilities $34.5K9 $12.9M4 $16.5M5 $14.0M6 $19.3M3 $23.6M3 Long-term debt $650.0K4 $1.1M5 $750.0K6 Total liabilities $34.5K9 $27.0M4 $24.8M5 $28.0M6 $32.2M3 $43.4M3 Shareholders’ equity -$34.5K9 -$65.1M4 $3.1M6 $24.1M3 $1.5M3 $23.3M3 Shares outstanding 5.0M shares9 833.5K shares4 26.9M shares5 37.4M shares6 37.4M shares3 48.6M shares3
Cash from operations4 5 6 3 -$15.4M in 2023+5% since 2019 -$20.0M -$15.0M -$10.0M -$5.0M 0 2019: -$14.6M -$14.6M 2019 2020: -$14.4M -$14.4M 2020 −2% 2021: -$18.6M -$18.6M 2021 +29% 2022: -$16.8M -$16.8M 2022 −10% 2023: -$15.4M -$15.4M 2023 −8% Capital spending4 5 6 3 $3.1M in 2023+277% since 2019 0 $1.0M $2.0M $3.0M $4.0M 2019: $823.0K $823.0K 2019 2020: $647.0K $647.0K 2020 −21% 2021: $611.0K $611.0K 2021 −6% 2022: $1.4M $1.4M 2022 +130% 2023: $3.1M $3.1M 2023 +121% Free cash flow4 5 6 3 -$18.5M in 2023+20% since 2019 -$20.0M -$15.0M -$10.0M -$5.0M 0 2019: -$15.5M -$15.5M 2019 2020: -$15.0M -$15.0M 2020 −3% 2021: -$19.2M -$19.2M 2021 +28% 2022: -$18.2M -$18.2M 2022 −5% 2023: -$18.5M -$18.5M 2023 +2% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2018 2019 2020 2021 2022 2023 Cash from operations -$14.6M4 -$14.4M5 -$18.6M6 -$16.8M3 -$15.4M3 Capital spending $823.0K4 $647.0K5 $611.0K6 $1.4M3 $3.1M3 Free cash flow -$15.5M -$15.0M -$19.2M -$18.2M -$18.5M
Compare Augmedix, Inc. with another company
Former names
Malo Holdings Corp Mar 14, 2019 to Oct 1, 20202
Recent filings
Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 Oct 4, 2024 4 OWNERSHIP DOCUMENTOct 4, 2024 4 OWNERSHIP DOCUMENTOct 2, 2024 8-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
